References
Blalock, J. E., & Smith, E. M. (1981). Human leukocyte interferon (HuIFN-a): potent endorphin-like opioid activity.Biochemical and Biophysics Research Communication, 101, 472–78.
Hill, N. O., Pardue, A., Khan, A., Aleman, C., Dorn, G., & Hill, J. M. (1981). Phase 1 human leukocyte interferon trials in cancer and leukemia.Journal of Clinical Hematology and Oncology, 11, 23–35.
Kurane, I., Innis, B. L., Nimmannitya, S., Nisalak, A., Meager, A., & Ennis, F. A. (1993). High levels of interferon alpha in the sera of children with dengue virus infection.American Journal of Tropical Medicine and Hygiene, 48, 222–229.
Singh, V. K., Warren, R. P., Odell, J. D., & Cole, P. (1991). Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children.Clinical Immunology and Immunopathology, 61, 448–455.
Skurkovich, S., Skurkovich, B., & Bellanti, J. A. (1987). A unifying model of the immunoregulatory role of the interferon system: can interferon produce disease in humans?Clinical Immunology and Immunopathology, 43, 362–373.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stubbs, G. Letter to the editor. J Autism Dev Disord 25, 71–73 (1995). https://doi.org/10.1007/BF02178169
Issue Date:
DOI: https://doi.org/10.1007/BF02178169